When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Why Cassava Sciences Stock Is Sinking Today - AOL

   www.aol.com/why-cassava-sciences-stock-sinking...

   Before you buy stock in Cassava Sciences, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Cassava ...

3. There’s Opportunity Brewing in Cassava Stock, Says Analyst

   www.aol.com/news/opportunity-brewing-cassava...

   If volatility is not your bag, then definitely stay away from Cassava Sciences (SAVA) stock. This biotech has been one of 2021’s most volatile, not to mention, controversial names. Ultimately ...

4. Why Cassava Sciences Stock Dived by Almost 11% Today - AOL

   www.aol.com/why-cassava-sciences-stock-dived...

   Science & Tech. Shopping. Sports

5. 2 Signals to Watch Before Buying SAVA Stock - AOL

   www.aol.com/news/2-signals-watch-buying-sava...

   Cassava Sciences (NASDAQ:SAVA) stock took off once again during September. Rumors about the Securities and Exchange Commission (or SEC) clearing its investigation of the scandal-tarnished biotech ...

6. A New Study Makes Cassava Sciences Stock an Interesting Buy - AOL

   www.aol.com/news/study-makes-cassava-sciences...

   Since making some big moves last month Cassava Sciences (NASDAQ:SAVA) stock has largely traded sideways. Yet while SAVA stock has been acting less wild, don’t blame it on a lack of new developments.

7. Cassava Stock: Despite Overhangs, the Risk-Reward Looks ... - AOL

   www.aol.com/news/cassava-stock-despite-overhangs...

   It’s been a miserable week for investors in clinical-stage biotechnology company Cassava Sciences (SAVA). The stock tumbled over 20% following a fireside chat, where CEO Remi Barbier outlined ...

8. Cassava Sciences Stock at $110 a Share? This Analyst ... - AOL

   www.aol.com/news/cassava-sciences-stock-110...

   Alzheimer’s disease (AD) is a notoriously difficult condition to treat. In fact, there are currently no available drugs that can halt the advancement of the memory-destroying disease. Finding a ...

9. Why Cassava Sciences Is Still a High-Risk Play - AOL

   www.aol.com/news/why-cassava-sciences-still-high...

   This news caused the stock, at one time a meme favorite, to tank. It fell from well over $100 to less than $50 per share. ... Since last August, biotech firm Cassava Sciences (NASDAQ:SAVA) has had ...